BRFXF - B-COMPLEX VITAMIN

Product Identification

Product ID:B-COMPLEX VITAMIN
MSDS Date:01/01/1994
FSC:6505
NIIN:01-354-7013
MSDS Number: BRFXF

Responsible Party
FUJISAWA PHARMACEUTICAL CO
PARKWAY NORTH CENTER, 3 PARKWAY N
DEERFIELD, IL 60015-2548
US

Emergency Phone: 800-888-7704

Info Phone: 708-317-0800

Preparer: CHRISTINA J. BARRINGTON

Cage: EO410

Contractor
LYPHOMED INC DIV OF FUJISAWA USA INC
MELROSE PARK, IL 60160-1112 US

Telephone: 312-345-6170

Cage: 60567

Ingredients

THIAMINE HYDROCHLORIDE - 200 MG/VIAL

CAS: 67-03-8

RTECS: XI7350000


RIBOFLAVIN - 30 MG/VIAL

CAS: 83-88-5

RTECS: VJ1400000


PYRIDOXINE HYDROCHLORIDE - 50 MG/VIAL

CAS: 58-56-0

RTECS: UV1350000


DEXPANTHENOL - 50 MG/VIAL

CAS: 81-13-0

RTECS: ES4316000


NIACINAMIDE - 750 MG/VIAL

CAS: 98-92-0

RTECS: QS3675000


CYANOCOALAMIN - 10,000 MICROGRAMS/VIAL

CAS: 68-19-9

RTECS: GG3750000


ASCORBIC ACID - 1000 MG/VIAL

CAS: 50-81-7

RTECS: CI7650000

OSHA PEL NOT EXTABLISHED


BENZYL ALCOHOL

CAS: 100-51-6

RTECS: DN3150000

Fraction By Weight: 0.9%


METHYL PARABEN - 18 MG/VIAL

CAS: 99-76-3

RTECS: DH2450000


PROPYL PARABEN - 2 MG/VIAL

CAS: 94-13-3

RTECS: DH2800000


SODIUM METABISULFITE - 1 MG/VIAL

CAS: 7681-57-4

RTECS: UX8225000

OSHA PEL 5 MG/M3

ACGIH TLV: 5 MG/M3; 9293


WATER

CAS: 7732-18-5

RTECS: ZC0110000


SULFURIC ACID (SARA III) USED ONLY WHEN PH ADJUSTMENT IS

CAS: 7664-93-9

RTECS: WS5600000

OSHA PEL 1 MG/M3

ACGIH TLV: 1 MG/M3; 9293

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS


SODIUM HYDROXIDE (SARA III) USED ONLY WHEN PH ADJUSTMENT

CAS: 1310-73-2

RTECS: WB4900000

OSHA PEL 2 MG/M3

ACGIH TLV: C 2 MG/M3; 9293

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

Hazards

LD50 LC50 Mixture:LD50: NOT GIVEN
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYE, SKIN AND RESPIRATORY IRRITATION
MAY OCCUR. NOTE: PRODUCT INTENDED FOR THERAPEUTIC USE ONLY WHEN
PRESCRIBED BY A PHYSICIAN.
Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT
CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT
CARCINOGENS.
Effects of Overexposure:EYE IRRITATION, SKIN IRRITATION, RESPIRATORY
IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISITNG SKIN AND RESPIRATORY
CONDITIONS MAY BE ADVERSELY AFFECTED BY EXPOSURE.

First Aid

First Aid:INHALATION: MOVE PERSON TO FRESH AIR IMMEDIATELY. GIVE
ARTIFICIAL RESPIRATION AND CPR IF REQUIRED. SEEK MEDICAL ATTENTION.
INGESTION: FLUSH MOUTH WITH WATER IMMEDIATELY. SEEK MEDICAL
ATTENTION. SKIN: REMOVE CONTAMINATED CLOTHING IMMEDIATELY. FLUSH
AREA WITH WATER. SEEK MEDICAL ATTENTION. EYES: IMMEDIATELY FLUSH
WITH WATER FOR AT LEAST 15 MINUTES. SEEK MEDICAL ATTENTION.

Fire Fighting

Flash Point:NONFLAMMABLE
Lower Limits:NOT GIVEN
Upper Limits:NOT GIVEN
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CARBON DIOXIE OR FOAM AS
APPRORPIATE
Fire Fighting Procedures:WEAR FIRE FIGHTING PROTECTIVE EQUIPMENT AND
FULL FACE-PIECE SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:WHEN HEATED TO DECOMPOSITION IT EMITS
TOXIC FUMES.

Accidental Release

Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. USE ABSORBENT TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE
SURFACES CLEAN AND WASH WITH SOAP AND WATER.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling

Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
AVOID ALL CONTACT AND INHALATION OF DUST, FUMES, MISTS AND/OR VAPOR
ASSOCIATED WITH THE PRODUCT.
Other Precautions:FOR ADVERSE DRUG REACTION INFORMATION, CALL
708-317-5937.

Exposure Controls

Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
PROTECTION NOT USUALLY REQUIRED.
Ventilation:GENERAL ROOM VENTILATION IS USUALLY SATISFACTORY, USE LOCAL
EXHAUST VENTIALTION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES OR GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS IF DIRECT SKIN CONTACT
IS ANTICIPATED.
Work Hygienic Practices:WASH WITH SOAP AND WATER AFTER HANDLING PRODUCT
AND BEFORE EATING DRINKING OR SMOKING.
Supplemental Safety and Health
POTENTIAL ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
DESCRIBED MORE FULLY IN THE PACKAGE INSERT. OCCUPATIONL EXPOSURE
HAS NOT BEEN FULLY INVESTIGATED.

Chemical Properties

HCC:N1
NRC/State Lic Num:NONE
Boiling Pt:B.P. Text:NOT GIVEN
Melt/Freeze Pt:M.P/F.P Text:NOT GIVEN
Vapor Pres:NOT GIVEN
Vapor Density:NOT GIVEN
Spec Gravity:NOT GIVEN
Evaporation Rate & Reference:NOT GIVEN
Solubility in Water:SOLUBLE
Appearance and Odor:COVIAL, RED SOLUTION UPPER CHAMBER AND YELLOW
POWDER LOWER CHAMBER.

Stability

Stability Indicator/Materials to Avoid:YES
NONE SPECIFIED BY MANUFACTURER.
Stability Condition to Avoid:PROTECT FROM FREEZING
Hazardous Decomposition Products:SMOKE

Disposal

Waste Disposal Methods:PREVENT WASTE FROM CONTAMINATING SURROUNDING
ENVIRONMENT. DISCARD ANY PRODUCT, RESIDUE, DISPOSAL CONTAINER OR
LINER IN ACCORDANCE WITH ALL FEDERAL, STATE AND LOCAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.